Cargando…

Maternal supplementation with Limosilactobacillus reuteri FN041 for preventing infants with atopic dermatitis: study protocol for a randomized controlled trial

BACKGROUND: Atopic dermatitis (AD) has increased rapidly with rapid urbanization; however, the treatment options for AD are lacking because the commonly used therapies can only alleviate symptoms. Limosilactobacillus reuteri (L. reuteri), FN041 is a specific strain isolated from human breast milk, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Renqiang, Ma, Yizhe, Luo, Zichen, Qi, Ce, Xie, Anni, Jiang, Yifan, Zhu, Baoli, Sun, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588667/ https://www.ncbi.nlm.nih.gov/pubmed/37869669 http://dx.doi.org/10.3389/fmicb.2023.1267448

Ejemplares similares

Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission
por: Zhou, Jingbo, et al.
Publicado: (2022)

Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications
por: Luo, Zichen, et al.
Publicado: (2023)

Limosilactobacillus reuteri Attenuates Atopic Dermatitis via Changes in Gut Bacteria and Indole Derivatives from Tryptophan Metabolism
por: Fang, Zhifeng, et al.
Publicado: (2022)

Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms
por: Peng, Yijing, et al.
Publicado: (2023)

Limosilactobacillus reuteri in Health and Disease
por: Abuqwider, Jumana, et al.
Publicado: (2022)

Prevention of High-Fat Diet-Induced Hypercholesterolemia by Lactobacillus reuteri Fn041 Through Promoting Cholesterol and Bile Salt Excretion and Intestinal Mucosal Barrier Functions
por: Lu, Mengyao, et al.
Publicado: (2022)

Lactobacillus for the treatment and prevention of atopic dermatitis: Clinical and experimental evidence
por: Xie, Anni, et al.
Publicado: (2023)

Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
por: Piccioni, Andrea, et al.
Publicado: (2021)

Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri
por: Luo, Hao, et al.
Publicado: (2021)

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
por: Saviano, Angela, et al.
Publicado: (2021)

Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection
por: Dargenio, Costantino, et al.
Publicado: (2021)

Effect of Coix Seed Extracts on Growth and Metabolism of Limosilactobacillus reuteri
por: Yang, Zhoujie, et al.
Publicado: (2022)

Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572
por: Diez-Echave, Patricia, et al.
Publicado: (2021)

Spontaneous Riboflavin-Overproducing Limosilactobacillus reuteri for Biofortification of Fermented Foods
por: Spacova, Irina, et al.
Publicado: (2022)

Limosilactobacillus reuteri inhibits the acid tolerance response in oral bacteria
por: Boisen, Gabriella, et al.
Publicado: (2023)

The Effect of Limosilactobacillus reuteri on Social Behavior Is Independent of the Adaptive Immune System
por: Dooling, Sean W., et al.
Publicado: (2022)

Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659
por: Sendelius, Malin, et al.
Publicado: (2023)

Probiotic Limosilactobacillus Reuteri (Lactobacillus Reuteri) Extends the Lifespan of Drosophila Melanogaster through Insulin/IGF-1 Signaling
por: Lee, Hye-Yeon, et al.
Publicado: (2023)

Anti-Amnesic Effect of Synbiotic Supplementation Containing Corni fructus and Limosilactobacillus reuteri in DSS-Induced Colitis Mice
por: Lee, Hyo Lim, et al.
Publicado: (2022)

Genome Sequence of the Reuterin-Producing Strain Limosilactobacillus reuteri INIA P572
por: Rodríguez-Mínguez, Eva, et al.
Publicado: (2021)

Development of probiotics beverage using cereal enzymatic hydrolysate fermented with Limosilactobacillus reuteri
por: Yang, Zhoujie, et al.
Publicado: (2022)

Lactobacillus (Limosilactobacillus) reuteri: a probiotic candidate to reduce neonatal diarrhea in calves
por: Schwaiger, Karin, et al.
Publicado: (2023)

Draft genome sequence of Limosilactobacillus reuteri, isolated from human breast milk
por: Tyagi, Akanksha, et al.
Publicado: (2023)

Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
por: Lavalle, Luca, et al.
Publicado: (2023)

Assessment of the efficacy of a feed additive consisting of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) DSM 32203 for dogs (NBF LANES)
por: Bampidis, Vasileios, et al.
Publicado: (2022)

Application of Lactobacillus reuteri B1/1 (Limosilactobacillus reuteri) Improves Immunological Profile of the Non-Carcinogenic Porcine-Derived Enterocytes
por: Karaffová, Viera, et al.
Publicado: (2023)

Limosilactobacillus balticus sp. nov., Limosilactobacillus agrestis sp. nov., Limosilactobacillus albertensis sp. nov., Limosilactobacillus rudii sp. nov. and Limosilactobacillus fastidiosus sp. nov., five novel Limosilactobacillus species isolated from the vertebrate gastrointestinal tract, and proposal of six subspecies of Limosilactobacillus reuteri adapted to the gastrointestinal tract of specific vertebrate hosts
por: Li, Fuyong, et al.
Publicado: (2021)

A Phylogenetic View on the Role of Glycerol for Growth Enhancement and Reuterin Formation in Limosilactobacillus reuteri
por: Zhang, Zhihong, et al.
Publicado: (2020)

Distinct B cell subsets in Peyer’s patches convey probiotic effects by Limosilactobacillus reuteri
por: Liu, Hao-Yu, et al.
Publicado: (2021)

Integrative growth physiology and transcriptome profiling of probiotic Limosilactobacillus reuteri KUB-AC5
por: Jatuponwiphat, Theeraphol, et al.
Publicado: (2021)

In Silico Genomic and Metabolic Atlas of Limosilactobacillus reuteri DSM 20016: An Insight into Human Health
por: Smythe, Paisleigh, et al.
Publicado: (2022)

Characterization of adhesion between Limosilactobacillus reuteri and milk phospholipids by density gradient and gene expression
por: Zhang, Lin, et al.
Publicado: (2020)

The probiotic and immunomodulation effects of Limosilactobacillus reuteri RGW1 isolated from calf feces
por: Huang, Kailang, et al.
Publicado: (2023)

Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice
por: Lee, Hana, et al.
Publicado: (2022)

Immunomodulatory Effect of Lactobacillus reuteri (Limosilactobacillus reuteri) and Its Exopolysaccharides Investigated on Epithelial Cell Line IPEC-J2 Challenged with Salmonella Typhimurium
por: Kiššová, Zuzana, et al.
Publicado: (2022)

Reuterin-producing Limosilactobacillus reuteri: Optimization of in situ reuterin production in alginate-based filmogenic solutions
por: Rodrigues, F.J., et al.
Publicado: (2021)

Flow cytometric analysis reveals culture condition dependent variations in phenotypic heterogeneity of Limosilactobacillus reuteri
por: Rao, Nikhil Seshagiri, et al.
Publicado: (2021)

Metagenomic Association Analysis of Gut Symbiont Limosilactobacillus reuteri Without Host-Specific Genome Isolation
por: Park, Sein, et al.
Publicado: (2020)

Limosilactobacillus reuteri Fermented Brown Rice: A Product with Enhanced Bioactive Compounds and Antioxidant Potential
por: Tyagi, Akanksha, et al.
Publicado: (2021)

Investigating Differential Expressed Genes of Limosilactobacillus reuteri LR08 Regulated by Soybean Protein and Peptides
por: Zhu, Shuya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_relbfn3uujb3np575eqb6qte52